Adarza BioSystems closes $5 mln Series B
Adarza BioSystems Inc closed a $5 million Series B financing round led by Cultivation Capital, Lewis and Clark Ventures and Siemens' venture capital unit. Adarza, which has operations in Rochester, New York and St. Louis, Missouri, is a developer of label-free biosensor assays and instruments.
21 March 2016•4 mins read
